Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
IGBP1 pseudogene 5 is a human genomic region classified as a pseudogene—a non-functional copy derived from the protein-coding gene IGBP1. Pseudogenes like IGBP1P5 are generally not transcribed into functional protein and are not considered direct therapeutic targets. There is no substantive evidence that IGBP1P5 plays a regulatory, disease, or biomarker role. Studies and databases reference related pseudogenes such as IGBP1P1, which have been implicated as non-coding RNAs with possible roles in cardiovascular disease, but such functions do not directly apply to IGBP1P5 as of the current literature[3][5][7].\n\nKey Points:\n- IGBP1P5 is a pseudogene, distinct from its protein-coding relative, IGBP1[5][8].\n- It is *not a receptor, enzyme, transporter, or other therapeutic target* type[5][7].\n- No known biological function, disease association, or interacting drugs have been reported for IGBP1P5[5][7].\n- The entry appears to be mis-specified as a therapeutic target, hence is_incorrect: true.\n\nAdditional context:\n- The parent gene IGBP1 is involved in protein phosphatase regulation and immune system signaling[1][8], but this is not applicable to pseudogene 5.\n- Some other IGBP1 pseudogenes (e.g., IGBP1P1) have recently been investigated for potential non-coding RNA functions, but there's no evidence for such a role for IGBP1P5 specifically[3].\n\nSummary of correctness:\nIGBP1P5 is not a valid or recognized drug target. Requests for clinical or mechanistic details about this pseudogene are unlikely to yield meaningful or actionable data at this time[5][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Immunoglobulin (CD79A) binding protein 1 pseudogene 5 (IGBP1P5).